Compare BCYC & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCYC | FRA |
|---|---|---|
| Founded | 2009 | 2003 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.7M | 415.1M |
| IPO Year | 2019 | N/A |
| Metric | BCYC | FRA |
|---|---|---|
| Price | $4.84 | $11.09 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $13.90 | N/A |
| AVG Volume (30 Days) | ★ 422.2K | 135.5K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.06% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.24 | $10.50 |
| 52 Week High | $9.55 | $13.41 |
| Indicator | BCYC | FRA |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 53.50 |
| Support Level | $4.24 | $10.94 |
| Resistance Level | $5.41 | $11.19 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 15.04 | 74.55 |
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.